Skip to content

Clinical trials

Recruiting Pulmonary Disease, Chronic Obstructive trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Pulmonary Disease, Chronic Obstructive Status: Recruiting Country / region: Germany Clear all

26 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20181
20223
20231
20245
202513
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting26

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca4
Sanofi4
GlaxoSmithKline3
RWTH Aachen University2
Apreo Health, Inc.1
Ayham Daher1
Eli Lilly and Company1
Fraunhofer-Institute of Toxicology and Experimental Medicine1
Grifols Therapeutics LLC1
IHF GmbH - Institut für Herzinfarktforschung1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Pulmonary Disease, Chronic Obstructive26
Emphysema7
Pulmonary Emphysema3
Asthma2
Lung Diseases2
Lung Diseases, Obstructive2
Respiratory Tract Diseases2
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis1
Arthritis, Psoriatic1
Arthritis, Rheumatoid1

Trials

Showing 1 to 25 of 26. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.